======= PTPRJ ======= == Gene Information == * **Official Symbol**: PTPRJ * **Official Name**: protein tyrosine phosphatase receptor type J * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5795|5795]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q12913|Q12913]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PTPRJ&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PTPRJ|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600925|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes, including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region containing five fibronectin type III repeats, a single transmembrane region, and a single intracytoplasmic catalytic domain, and thus represents a receptor-type PTP. This protein is present in all hematopoietic lineages, and was shown to negatively regulate T cell receptor signaling possibly through interfering with the phosphorylation of Phospholipase C Gamma 1 and Linker for Activation of T Cells. This protein can also dephosphorylate the PDGF beta receptor, and may be involved in UV-induced signal transduction. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Tyrosine phosphatase which dephosphorylates or contributes to the dephosphorylation of CTNND1, FLT3, PDGFRB, MET, RET (variant MEN2A), KDR, LYN, SRC, MAPK1, MAPK3, EGFR, TJP1, OCLN, PIK3R1 and PIK3R2. Plays a role in cell adhesion, migration, proliferation and differentiation. Involved in vascular development. Regulator of macrophage adhesion and spreading. Positively affects cell-matrix adhesion. Positive regulator of platelet activation and thrombosis. Negative regulator of cell proliferation. Negative regulator of PDGF-stimulated cell migration; through dephosphorylation of PDGFR. Positive regulator of endothelial cell survival, as well as of VEGF-induced SRC and AKT activation; through KDR dephosphorylation. Negative regulator of EGFR signaling pathway; through EGFR dephosphorylation. Enhances the barrier function of epithelial junctions during reassembly. Negatively regulates T-cell receptor (TCR) signaling. Upon T-cell TCR activation, it is up-regulated and excluded from the immunological synapses, while upon T-cell-antigen presenting cells (APC) disengagement, it is no longer excluded and can dephosphorylate PLCG1 and LAT to down-regulate prolongation of signaling. {ECO:0000269|PubMed:10821867, ECO:0000269|PubMed:11259588, ECO:0000269|PubMed:12062403, ECO:0000269|PubMed:12370829, ECO:0000269|PubMed:12475979, ECO:0000269|PubMed:12913111, ECO:0000269|PubMed:14709717, ECO:0000269|PubMed:16682945, ECO:0000269|PubMed:16778204, ECO:0000269|PubMed:18348712, ECO:0000269|PubMed:18936167, ECO:0000269|PubMed:19332538, ECO:0000269|PubMed:19494114, ECO:0000269|PubMed:19836242, ECO:0000269|PubMed:19922411, ECO:0000269|PubMed:21091576, ECO:0000269|PubMed:21262971, ECO:0000269|PubMed:9531590, ECO:0000269|PubMed:9780142}. |Y phosphatase| |fn3| |positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis| |delta-catenin binding| |positive regulation of Fc receptor mediated stimulatory signaling pathway| |regulation of Fc-gamma receptor signaling pathway involved in phagocytosis| |contact inhibition| |gamma-catenin binding| |negative regulation of vascular permeability| |regulation of Fc receptor mediated stimulatory signaling pathway| |negative regulation of platelet-derived growth factor receptor signaling pathway| |platelet-derived growth factor receptor binding| |negative regulation of T cell receptor signaling pathway| |mitogen-activated protein kinase binding| |regulation of platelet-derived growth factor receptor signaling pathway| |calcium-mediated signaling using intracellular calcium source| |positive regulation of focal adhesion assembly| |negative regulation of antigen receptor-mediated signaling pathway| |positive regulation of adherens junction organization| |platelet-derived growth factor receptor signaling pathway| |positive regulation of cell junction assembly| |regulation of vascular permeability| |immunological synapse| |regulation of T cell receptor signaling pathway| |negative regulation of protein kinase B signaling| |negative regulation of epidermal growth factor receptor signaling pathway| |phosphatase activity| |positive chemotaxis| |negative regulation of ERBB signaling pathway| |positive regulation of cell-matrix adhesion| |regulation of cell-substrate junction assembly| |regulation of focal adhesion assembly| |regulation of antigen receptor-mediated signaling pathway| |regulation of adherens junction organization| |positive regulation of phagocytosis| |negative regulation of MAP kinase activity| |beta-catenin binding| |regulation of epidermal growth factor receptor signaling pathway| |positive regulation of tumor necrosis factor production| |positive regulation of tumor necrosis factor superfamily cytokine production| |regulation of cell junction assembly| |regulation of ERBB signaling pathway| |specific granule membrane| |regulation of phagocytosis| |ruffle membrane| |protein tyrosine phosphatase activity| |peptidyl-tyrosine dephosphorylation| |B cell differentiation| |regulation of cell-matrix adhesion| |positive regulation of cell-substrate adhesion| |negative regulation of protein serine/threonine kinase activity| |calcium-mediated signaling| |regulation of tumor necrosis factor production| |regulation of tumor necrosis factor superfamily cytokine production| |B cell activation| |positive regulation of protein kinase B signaling| |negative regulation of MAPK cascade| |vascular process in circulatory system| |cell-cell junction| |T cell receptor signaling pathway| |negative regulation of cell growth| |positive regulation of peptidyl-tyrosine phosphorylation| |regulation of cell-substrate adhesion| |protein dephosphorylation| |positive regulation of immune effector process| |regulation of protein kinase B signaling| |negative regulation of protein kinase activity| |lymphocyte differentiation| |negative regulation of growth| |negative regulation of kinase activity| |regulation of peptidyl-tyrosine phosphorylation| |negative regulation of cell migration| |negative regulation of cell motility| |negative regulation of transferase activity| |antigen receptor-mediated signaling pathway| |dephosphorylation| |negative regulation of cellular component movement| |cadherin binding| |negative regulation of locomotion| |leukocyte differentiation| |second-messenger-mediated signaling| |regulation of MAP kinase activity| |lymphocyte activation| |blood circulation| |circulatory system process| |positive regulation of cell adhesion| |negative regulation of protein phosphorylation| |regulation of cell growth| |negative regulation of immune system process| |negative regulation of phosphorylation| |immune response-activating cell surface receptor signaling pathway| |positive regulation of cytokine production| |protein kinase binding| |regulation of immune effector process| |immune response-regulating cell surface receptor signaling pathway| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |negative regulation of intracellular signal transduction| |leukocyte degranulation| |transmembrane receptor protein tyrosine kinase signaling pathway| |regulation of protein serine/threonine kinase activity| |myeloid leukocyte mediated immunity| |positive regulation of cellular component biogenesis| |myeloid cell activation involved in immune response| |positive regulation of MAPK cascade| |chemotaxis| |regulation of vesicle-mediated transport| |taxis| |hemopoiesis| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |immune response-activating signal transduction| |myeloid leukocyte activation| |negative regulation of protein modification process| |immune response-regulating signaling pathway| |hematopoietic or lymphoid organ development| |cell surface| |leukocyte activation involved in immune response| |cell activation involved in immune response| |activation of immune response| |immune system development| |regulation of growth| |negative regulation of cell population proliferation| |regulation of cell adhesion| |regulation of cytokine production| |regulated exocytosis| |enzyme linked receptor protein signaling pathway| |regulation of MAPK cascade| |leukocyte mediated immunity| |negative regulation of catalytic activity| |exocytosis| |regulation of protein kinase activity| |regulation of cell migration| |positive regulation of immune response| |regulation of kinase activity| |regulation of cell motility| |leukocyte activation| |regulation of cellular component biogenesis| |regulation of transferase activity| |regulation of locomotion| |positive regulation of transport| |regulation of cellular component movement| |secretion by cell| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |negative regulation of cellular protein metabolic process| |export from cell| |positive regulation of phosphorylation| |cell activation| |immune effector process| |negative regulation of protein metabolic process| |secretion| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |negative regulation of molecular function| |regulation of immune response| |positive regulation of immune system process| |positive regulation of cellular component organization| |positive regulation of protein modification process| |negative regulation of signal transduction| |locomotion| |negative regulation of cell communication| |negative regulation of signaling| |integral component of plasma membrane| |regulation of protein phosphorylation| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |negative regulation of response to stimulus| |positive regulation of signal transduction| |regulation of immune system process| |intracellular signal transduction| |positive regulation of protein metabolic process| |positive regulation of multicellular organismal process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |regulation of transport| |immune response| |vesicle-mediated transport| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp244|SB743921 0.001μM R05 exp244]]|-2.17| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|-2.05| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|-2| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|1.81| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|1.86| |[[:results:exp120|Dimethyl-Sulfoxide 1pc R03 exp120]]|1.91| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.48| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12923 * **Expression level (log2 read counts)**: 5.7 {{:chemogenomics:nalm6 dist.png?nolink |}}